Dorato Capital Management bought 4,799 shares of Amgen Inc. for about $1.58 million, marking it as their 21st-largest holding. Amgen's strong Q4 results exceeded estimates, leading to optimistic 2026 guidance and increased price targets despite a mixed analyst outlook.

NodeGuardian

2026-04-17 06:57:10

Abstract generation in progress

Dorato Capital Management has acquired a new position in Amgen Inc. (NASDAQ:AMGN), purchasing 4,799 shares valued at approximately $1.58 million, making it their 21st-largest holding. Amgen recently reported strong Q4 earnings, surpassing analyst estimates for both EPS and revenue, and has issued optimistic FY2026 guidance. Despite mixed analyst sentiment, with an average “Hold” rating, several price targets have been increased, and the company has declared a quarterly dividend of $2.52 per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
189.14K Popularity
#
Gate13thAnniversaryLive
743.27K Popularity
#
AltcoinsRallyStrong
7.31M Popularity
#
AnthropicvsOpenAIHeatsUp
1.06M Popularity
#
KalshiFacesNevadaRegulatoryClash
459.14K Popularity

Sitemap

Dorato Capital Management Invests $1.58 Million in Amgen Inc. $AMGN

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

AltcoinsRallyStrong

AnthropicvsOpenAIHeatsUp

KalshiFacesNevadaRegulatoryClash

Pin